Log in

Start Your Membership Now

The Indiana Medicaid program has proposed limiting applied behavior analysis (ABA) coverage to 30 hours per week for children at autism spectrum disorder level 1 and creating a three-year lifetime cap on ABA coverage. Some exceptions to the lifetime cap would be available, based on medical necessity. The new policy is slated to go into effect on April 1, 2025, or as soon as the Centers for Medicare & Medicaid Services (CMS) approves a state plan amendment (SPA) for these changes. The state anticipates that annual expenditures for ABA will decline.

The Indiana Family and Social Services Administration (FSSA . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Autism & I/DD

Intellectual and developmental disabilities (I/DD) are a physical and/or cognitive impairments that occur before the age of 22. Autism spectrum disorder is generally considered a type of developmental disability that affects behaviour and communication. The autism and I/DD market provides supports and health care services to these populations. Over the past decade, there has been an increase in the changes and challenges affecting I/DD and autism markets—the move to managed care and value-based care, the shift away from residential treatment, the increasing emphasis on consumer-directed care, and new workforce challenges.

Editor’s Picks

Latest Resources
See All
90% Of Chilean Children With Autism Have Medical Comorbidities
About 90% of children with autism in Chile have at least one medical comorbidity. More than half had insomnia (61%) or were overweight (52%). About 28% had allergic rhinitis or atopic dermatitis, and 27% had constipation. Researchers analyzed a retrospective chart review of 544 children diagnosed with autism between 2015 and 2023 at a specialized pediatric neurodevelopmental center in Chile. The children’s comorbid medical conditions were identified through standardized caregiver interviews, clinical examination, body measurements,… Read

To sign-up for monthly Autism & I/DD Services alerts, you must be signed in to your account.

Government Contract Bidding Opportunities

Government Contract Award Announcements